NTAP vs STRO
NetApp Inc (NTAP) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
NetApp Inc (NTAP) is a software - infrastructure company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported NTAP revenue for 2025-04-25 was $6.57B. Net income was $1.19B. Revenue was up 4.9% from 2024-04-26 to 2025-04-25. NTAP currently screens at market cap $35.43B and trailing P/E 28.2.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
NTAP currently screens at market cap $35.43B and trailing P/E 28.2. STRO currently screens at market cap $470.8M.
Not investment advice. Open the NTAP and STRO stock pages for the full models.
Not investment advice.